Omnia Sana · Plant Monograph
Peppermint
Mentha × piperita
This monograph compiles 6 pharmacological actions, 13 traditional / indicated uses, supported by 13 cited sources, drawn directly from the Omnia Sana plant database.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
more plants for arthritis / joint pain →detailed sources →inferred from analgesic action
more plants for back pain →detailed sources →inferred from digestive action
more plants for bloating →detailed sources →inferred from analgesic action
more plants for headache →detailed sources →inferred from digestive action
more plants for indigestion →detailed sources →inferred from antimicrobial action
more plants for infection (general) →detailed sources →inferred from anti-inflammatory action
more plants for inflammation (general) →detailed sources →inferred from antispasmodic action
more plants for menstrual cramps →detailed sources →inferred from antispasmodic action
more plants for muscle spasm →detailed sources →inferred from anti-inflammatory action
more plants for skin irritation →detailed sources →inferred from antimicrobial action
more plants for wounds →detailed sources →Safety, Cautions & Contraindications
Generally very safe. Essential oil should not be applied to the face or chest of infants or children — menthol can cause respiratory depression. Avoid enteric-coated capsules if taking antacids or acid-suppressing drugs. May worsen GERD by relaxing the lower oesophageal sphincter. Avoid in bile duct obstruction and gallstones.
Duke (2002) rates peppermint as +++ with clinical evidence (score 2) for antispasmodic activity, consistent with Commission E approval for IBS (irritable bowel syndrome) using enteric-coated peppermint oil capsules. Enteric-coated peppermint oil is one of the most clinically validated herbal treatments for IBS, reducing abdominal pain and spasm. Dose: 0.6 ml enteric-coated oil two to three times daily between meals (for IBS); 1.5–3 g dried leaf as tea three times daily for digestive complaints. Peppermint should not be applied near the face or nostrils of infants and small children (risk of laryngospasm from menthol). Contraindicated in cholelithiasis (gallstones) (Duke, 2002).
References
REF-1203, REF-1204, REF-1205, REF-1206, REF-1207, REF-1208, REF-1209, REF-1210, REF-1211, REF-1212References & Sources
- McKay, D.L. and Blumberg, J.B (2006) 'A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.)', Phytotherapy Research, 20(8), pp. 619-633. doi:10.1002/ptr.1936 Meta-analysis / review
https://doi.org/10.1002/ptr.1936 - Mahendran, G. and Rahman, L.U (2020) 'Ethnomedicinal, phytochemical and pharmacological updates on Peppermint (Mentha x piperita L.)-A review', Phytotherapy Research, 34(9), pp. 2088-2139. doi:10.1002/ptr.6664 Meta-analysis / review
https://doi.org/10.1002/ptr.6664 - Zhao, H., Ren, S., Yang, H., Tang, S. and others (2022) 'Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application', Biomedicine & Pharmacotherapy, 154, pp. 113559. doi:10.1016/j.biopha.2022.113559 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2022.113559 - Keifer, D., Ulbricht, C., Abrams, T.R., Basch, E. and others (2007) 'Peppermint (Mentha piperita): an evidence-based systematic review by the Natural Standard Research Collaboration', Journal of Herbal Pharmacotherapy, 7(2), pp. 91-143. doi:10.1300/j157v07n02_07 Meta-analysis / review
https://doi.org/10.1300/j157v07n02_07 - Gobel, H., Heinze, A., Heinze-Kuhn, K., Gobel, A. and Gobel, C (2016) 'Peppermint oil in the acute treatment of tension-type headache', Schmerz, 30(3), pp. 295-310. doi:10.1007/s00482-016-0109-6 Meta-analysis / review
https://doi.org/10.1007/s00482-016-0109-6 - Nair, B (2001) 'Final report on the safety assessment of Mentha Piperita (Peppermint) Oil, Mentha Piperita (Peppermint) Leaf Extract, Mentha Piperita (Peppermint) Leaf, and Mentha Piperita (Peppermint) Leaf Water', International Journal of Toxicology, 20(Suppl 3), pp. 61-73. Meta-analysis / review
Find this source - Kobayashi, T., Sugaya, K., Onose, J. and Abe, N (2019) 'Peppermint (Mentha piperita) extract effectively inhibits cytochrome P450 3A4 (CYP3A4) mRNA induction in rifampicin-treated HepG2 cells', Bioscience, Biotechnology, and Biochemistry, 83(7), pp. 1181-1192. doi:10.1080/09168451.2019.1608802 Preclinical
https://doi.org/10.1080/09168451.2019.1608802 - Romero, M.C., Navarro, M.C., Martin-Sanchez, J. and Valero, A (2014) 'Peppermint (Mentha piperita) and albendazole against anisakiasis in an animal model', Tropical Medicine & International Health, 19(12), pp. 1430-1436. doi:10.1111/tmi.12399 Preclinical
https://doi.org/10.1111/tmi.12399 - Riachi, L.G. and De Maria, C.A.B (2015) 'Peppermint antioxidants revisited', Food Chemistry, 176, pp. 72-81. doi:10.1016/j.foodchem.2014.12.028 Meta-analysis / review
https://doi.org/10.1016/j.foodchem.2014.12.028 - Herro, E. and Jacob, S.E (2010) 'Mentha piperita (peppermint)', Dermatitis, 21(6), pp. 327-329. Preclinical
Find this source - Akdogan, M. et al (2004) 'Investigation of biochemical and histopathological effects of Mentha piperita labiatae and Mentha spicata labiatae on kidney tissue in rats', 23(7), pp. 321--327. Preclinical
Find this source - Grigoleit, H.G. and Grigoleit, P (2005) 'Peppermint oil in irritable bowel syndrome', 12(8), pp. 601--606. Randomized trial
Find this source - Mas-Coma, S (2004) 'Fasciolosis in humans'. Traditional / reference
Find this source
Generated June 22, 2026 from omniasana.bio